{
    "2020-05-11": [
        [
            {
                "time": "2020-06-15",
                "original_text": "The Dow Slipped 109 Points Because Reopened Economies Aren’t Business as Usual",
                "features": {
                    "keywords": [
                        "Dow",
                        "Slipped",
                        "Reopened Economies"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "AbbVie Stock Is ‘Unsustainably Cheap’ After Allergan Acquisition",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stock",
                        "Unsustainably Cheap",
                        "Allergan Acquisition"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "AbbVie Garners Two Favorable Analyst Reviews After Allergan Merger",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Favorable Analyst Reviews",
                        "Allergan Merger"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Valuation",
                        "Dividend Yield",
                        "Confidence in Guidance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Form 8.3 - AbbVie Inc.",
                "features": {
                    "keywords": [
                        "Form 8.3",
                        "AbbVie Inc."
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "regulatory"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "AbbVie Wraps Its $63 Billion Allergan Buyout — Is AbbVie Stock A Buy?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Allergan Buyout",
                        "Stock Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Form 8.3 - ABBVIE INC",
                "features": {
                    "keywords": [
                        "Form 8.3",
                        "ABBVIE INC"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "regulatory"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}